These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19673850)

  • 1. Toxicity in three dogs from accidental oral administration of a topical endectocide containing moxidectin and imidacloprid.
    See AM; McGill SE; Raisis AL; Swindells KL
    Aust Vet J; 2009 Aug; 87(8):334-7. PubMed ID: 19673850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal safety study with imidacloprid/moxidectin topical solution in the ivermectin-sensitive collie.
    Paul AJ; Hutchens DE; Firkins LD; Borgstrom M
    Vet Parasitol; 2004 May; 121(3-4):285-91. PubMed ID: 15135868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
    Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
    Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs.
    Fourie LJ; Du Rand C; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880
    [No Abstract]   [Full Text] [Related]  

  • 5. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of canine generalized demodicosis with a 'spot-on' formulation containing 10% moxidectin and 2.5% imidacloprid (Advocate, Bayer Healthcare).
    Mueller RS; Meyer D; Bensignor E; Sauter-Louis C
    Vet Dermatol; 2009 Oct; 20(5-6):441-6. PubMed ID: 20178482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs.
    von Samson-Himmelstjerna G; Epe C; Schimmel A; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S114-5. PubMed ID: 12928872
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigations into the prevention of neonatal Ancylostoma caninum infections in puppies by application of imidacloprid 10% plus moxidectin 2.5% topical solution to the pregnant dog.
    Krämer F; Epe C; Mencke N
    Zoonoses Public Health; 2009 Feb; 56(1):34-40. PubMed ID: 18793274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and management of moxidectin toxicity in two dogs.
    Snowden NJ; Helyar CV; Platt SR; Penderis J
    J Small Anim Pract; 2006 Oct; 47(10):620-4. PubMed ID: 17004957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a formulation containing imidacloprid and moxidectin in the treatment of lice infestation in guinea pigs.
    Kim SH; Jun HK; Yoo MJ; Kim DH
    Vet Dermatol; 2008 Jun; 19(3):187-8. PubMed ID: 18477336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anthelmintic efficacy and the safety of a combination of imidacloprid and moxidectin spot-on in cats and dogs under field conditions in Europe.
    Hellmann K; Knoppe T; Radeloff I; Heine J
    Parasitol Res; 2003 Jul; 90 Suppl 3():S142-3. PubMed ID: 12928883
    [No Abstract]   [Full Text] [Related]  

  • 12. Field efficacy and safety of a combination of moxidectin and imidacloprid for the prevention of feline heartworm (Dirofilaria immitis) infection.
    Venco L; Mortarino M; Carro C; Genchi M; Pampurini F; Genchi C
    Vet Parasitol; 2008 Jun; 154(1-2):67-70. PubMed ID: 18395348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R
    Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study.
    Becskei C; Cuppens O; Mahabir SP
    Vet Dermatol; 2018 Jun; 29(3):203-e72. PubMed ID: 29423956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European multicenter field trial on the efficacy and safety of a topical formulation of imidacloprid and permethrin (Advantix) in dogs naturally infested with ticks and/or fleas.
    Hellmann K; Knoppe T; Krieger K; Stanneck D
    Parasitol Res; 2003 Jul; 90 Suppl 3():S125-6. PubMed ID: 12928876
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative efficacy of the combination fipronil-(S)-methoprene and the combination permethrin-imidacloprid against Dermacentor reticulatus, the European dog tick, applied topically to dogs.
    Doyle V; Beugnet F; Carithers D
    Vet Ther; 2005; 6(4):303-10. PubMed ID: 16550492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of a topically applied imidacloprid 10 % / moxidectin 2.5 % formulation (Advocate®, Advantage® Multi, Bayer) against Immature and Adult Spirocerca lupi worms in experimentally infected dogs.
    Austin CM; Kok DJ; Crafford D; Schaper R
    Parasitol Res; 2013 Aug; 112 Suppl 1():91-108. PubMed ID: 23779222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the therapy of canine demodicosis.
    Mueller RS
    Compend Contin Educ Vet; 2012 Apr; 34(4):E1-4. PubMed ID: 22488596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of moxidectin overdose cases in equines from 1998 through 2000.
    Khan SA; Kuster DA; Hansen SR
    Vet Hum Toxicol; 2002 Aug; 44(4):232-5. PubMed ID: 12136974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.
    Fourie JJ; Delport PC; Fourie LJ; Heine J; Horak IG; Krieger KJ
    Parasitol Res; 2009 Aug; 105 Suppl 1():S115-24. PubMed ID: 19575232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.